Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 205 articles: HTML format

Single Articles

September 2025
1. MUELLER C, White HD, Lopez-Ayala P, de Silva R, et al
   Great debate: the universal definition of myocardial infarction is flawed and should be put to rest.
   Eur Heart J. 2025 Sep 9:ehaf641. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. 
   Correction to: Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
   Eur Heart J. 2025 Sep 8:ehaf708. doi: 10.1093.
   PubMed    
   
   
   
3. GIRAUD MN
   Macrophage leukotriene B4 production sustains inflammation after myocardial infarction.
   Eur Heart J. 2025 Sep 4:ehaf471. doi: 10.1093.
   PubMed    
   
   
   
4. CHEN Z, Song J, Feng S, Liu M, et al
   Arachidonic acid fuels inflammation by unlocking macrophage protein phosphatase 5 after myocardial infarction.
   Eur Heart J. 2025 Sep 4:ehaf493. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. AMICONE S, Fedele D, Pizzi C
   Revascularization in latecomer ST-elevation myocardial infarction patients: diverging ACC/AHA and ESC Guidelines.
   Eur Heart J. 2025 Sep 3:ehaf616. doi: 10.1093.
   PubMed    
   
   
   
6. GOULD KL, Johnson NP, Roby AE, Kirkeeide R, et al
   Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial.
   Eur Heart J. 2025;46:3273-3286.
   PubMed     Abstract available
   
   
   August 2025
7. ROSSELLO X, Dominguez-Rodriguez A, Latini R, Sanchez PL, et al
   Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial.
   Eur Heart J. 2025 Aug 30:ehaf673. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. KAWAGUCHI N, Ando R, Obata J
   A case of cardiopulmonary arrest on arrival due to acute myocardial infarction with immunoglobulin G4-related coronary periarteritis.
   Eur Heart J. 2025 Aug 29:ehaf632. doi: 10.1093.
   PubMed    
   
   
   
9. KRALER S, Mueller C, Libby P, Bhatt DL, et al
   Acute coronary syndromes: mechanisms, challenges, and new opportunities.
   Eur Heart J. 2025;46:2866-2889.
   PubMed     Abstract available
   
   
   July 2025
10. 
    Correction to: Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
    Eur Heart J. 2025 Jul 31:ehaf579. doi: 10.1093.
    PubMed    
    
    
    
11. PARADIES V, Masiero G, Rubboli A, Van Beusekom HMM, et al
    Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Eur Heart J. 2025;46:2730-2741.
    PubMed     Abstract available
    
    
    
12. MORZE J, Melloni GEM, Wittenbecher C, Ala-Korpela M, et al
    ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease.
    Eur Heart J. 2025;46:2691-2701.
    PubMed     Abstract available
    
    
    
13. 
    Correction to: Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
    Eur Heart J. 2025 Jul 10:ehaf510. doi: 10.1093.
    PubMed    
    
    
    
14. FEZZI S, Scheller B, Cortese B, Alfonso F, et al
    Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
    Eur Heart J. 2025;46:2498-2519.
    PubMed     Abstract available
    
    
    
15. NURMOHAMED NS, Ngo-Metzger Q, Taub PR, Ray KK, et al
    First myocardial infarction: risk factors, symptoms, and medical therapy.
    Eur Heart J. 2025 Jul 3:ehaf390. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
16. MILLER RJH, Yi J, Shanbhag A, Marcinkiewicz A, et al
    Deep learning-quantified body composition from positron emission tomography/computed tomography and cardiovascular outcomes: a multicentre study.
    Eur Heart J. 2025;46:2336-2347.
    PubMed     Abstract available
    
    
    
17. WANG S, Luo X, Hu S, Zhao C, et al
    Plaque erosion risk and JAK2 V617F variant.
    Eur Heart J. 2025;46:2205-2219.
    PubMed     Abstract available
    
    
    
18. WANG X, Xu Y, Yu C, Deng R, et al
    Periodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils.
    Eur Heart J. 2025;46:2223-2238.
    PubMed     Abstract available
    
    
    
19. TOVAL A, Bakker EA, Granada-Maia JB, Nunez de Arenas-Arroyo S, et al
    Exercise type and settings, quality of life, and mental health in coronary artery disease: a network meta-analysis.
    Eur Heart J. 2025;46:2186-2201.
    PubMed     Abstract available
    
    
    
20. ZEDER K, Mak S, Galie N, Rosenkranz S, et al
    Right heart catheterization in heart failure: indications, interpretation, and pitfalls.
    Eur Heart J. 2025 Jun 16:ehaf322. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. HASSAN IN, Ashraf H, Hasan A
    Sudan conflict: impact on interrupted care after acute myocardial infarction.
    Eur Heart J. 2025 Jun 12:ehaf313. doi: 10.1093.
    PubMed    
    
    
    
22. ARENAS-MONTES J, Alcala-Diaz JF, Garcia-Fernandez H, Gutierrez-Mariscal FM, et al
    A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study.
    Eur Heart J. 2025;46:2104-2115.
    PubMed     Abstract available
    
    
    
23. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
    Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
    Eur Heart J. 2025;46:2052-2062.
    PubMed     Abstract available
    
    
    
24. MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al
    Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis.
    Eur Heart J. 2025;46:2092-2100.
    PubMed     Abstract available
    
    
    
25. ALI ZA, Shin D, Vijayvergiya R, Gawalkar AA, et al
    Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial.
    Eur Heart J. 2025 Jun 5:ehaf331. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
26. KIM MC, Park SJ, Park DW, Ahn JM, et al
    Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial.
    Eur Heart J. 2025 May 29:ehaf273. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. PROCOPI N, Zeitouni M, Kerneis M, Cayla G, et al
    Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
    Eur Heart J. 2025 May 22:ehaf170. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. CLELAND JGF
    Staring into the AbetaYSS: how many pills and for how long after myocardial infarction?
    Eur Heart J. 2025 May 22:ehaf226. doi: 10.1093.
    PubMed    
    
    
    
29. HANSSON EC, Omerovic E, Venetsanos D, Alfredsson J, et al
    Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study.
    Eur Heart J. 2025 May 16:ehaf327. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. COYLE M, McEvoy JW
    Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction.
    Eur Heart J. 2025 May 9:ehaf308. doi: 10.1093.
    PubMed    
    
    
    
31. WANG J, Verkerk AO, Wilders R, Zhang Y, et al
    SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias.
    Eur Heart J. 2025;46:1747-1762.
    PubMed     Abstract available
    
    
    
32. PERRY CGR, Sweeney G
    Targeting mitochondrial fission for the treatment of myocardial infarction.
    Eur Heart J. 2025 May 6:ehaf296. doi: 10.1093.
    PubMed    
    
    
    
33. OIKONOMOU G, Cheng K, Mohiaddin RH
    CMR: a gatekeeper before ICA in a stable non ST-elevation myocardial infarction patient with severely impaired LV function.
    Eur Heart J. 2025 May 6:ehaf300. doi: 10.1093.
    PubMed    
    
    
    
34. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
    Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
    Eur Heart J. 2025;46:1586-1599.
    PubMed     Abstract available
    
    
    
35. WEYRICH M, Zewinger S, Sarakpi T, Rasper T, et al
    Mosaic loss of Y chromosome and mortality after coronary angiography.
    Eur Heart J. 2025;46:1603-1616.
    PubMed     Abstract available
    
    
    
36. ZHANG Q, Li H, Zhuang T, Xu L, et al
    CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
    Eur Heart J. 2025;46:1645-1658.
    PubMed     Abstract available
    
    
    
37. D'ENTREMONT MA, Poorthuis MHF, Fiolet ATL, Amarenco P, et al
    Colchicine for secondary prevention of vascular events: a meta-analysis of trials.
    Eur Heart J. 2025 May 2:ehaf210. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. SAMUEL M, Berry C, Dube MP, Koenig W, et al
    Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.
    Eur Heart J. 2025 May 2:ehaf174. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
39. CREA F
    Focus on heart failure: sex-related differences, new light shed on SGLT2i mechanism of action, and heart failure after myocardial infarction.
    Eur Heart J. 2025;46:1457-1461.
    PubMed    
    
    
    
40. MOLLER JE, Thiele H, Morrow D, Kjaergaard J, et al
    Mechanical circulatory support: when, how, and for whom.
    Eur Heart J. 2025;46:1480-1492.
    PubMed     Abstract available
    
    
    
41. CHEN J, Zhao J, Fu S
    Addressing sample overlap and meta-analysis imbalances in Mendelian randomization: a critical appraisal of protein targets for myocardial infarction.
    Eur Heart J. 2025 Apr 18:ehaf186. doi: 10.1093.
    PubMed    
    
    
    
42. TITOVA OE, Yuan S, Larsson SC
    Applying Mendelian randomization to study the relationship between circulating proteins and myocardial infarction.
    Eur Heart J. 2025 Apr 18:ehaf187. doi: 10.1093.
    PubMed    
    
    
    
43. BAY B, Tanner R, Gao M, Oliva A, et al
    Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
    Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. BOUGHANEM H, Herrero-Cervera A, Soehnlein O
    SiglecF+ neutrophils link periodontitis to impaired post-myocardial infarction repair.
    Eur Heart J. 2025 Apr 8:ehaf165. doi: 10.1093.
    PubMed    
    
    
    March 2025
45. CHIU IM, Ouyang D
    Acute myocardial infarction diagnosis: impact of artificial intelligence-powered ECG interpretation.
    Eur Heart J. 2025 Mar 25:ehaf142. doi: 10.1093.
    PubMed    
    
    
    
46. SOUZA ACDAH, Troschel AS, Marquardt JP, Hadzic I, et al
    Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes.
    Eur Heart J. 2025;46:1112-1123.
    PubMed     Abstract available
    
    
    
47. XU Y, Feng T, Huang Y
    Gender-specific associations and circulating proteins in myocardial infarction: potential causal relationships.
    Eur Heart J. 2025 Mar 7:ehaf111. doi: 10.1093.
    PubMed    
    
    
    
48. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
    Circulating proteins and incident myocardial infarction: appraising sex-specific differences and causality.
    Eur Heart J. 2025 Mar 7:ehaf113. doi: 10.1093.
    PubMed    
    
    
    
49. BOUZID Z, Sejdic E, Martin-Gill C, Faramand Z, et al
    Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome.
    Eur Heart J. 2025;46:943-954.
    PubMed     Abstract available
    
    
    
50. CLAESSEN G, Eijsvogels TMH, Albert CM, Baggish AL, et al
    Coronary atherosclerosis in athletes: emerging concepts and preventive strategies.
    Eur Heart J. 2025;46:890-903.
    PubMed     Abstract available
    
    
    
51. CALAFIORE AM, Prapas S, Gaudino M
    Arterial conduits for coronary bypass grafting: the set-point concept.
    Eur Heart J. 2025;46:922-925.
    PubMed     Abstract available
    
    
    
52. DANG QM, Psaltis PJ, Burgess S, Chandrasekhar J, et al
    The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.
    Eur Heart J. 2025 Mar 7:ehaf097. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
53. LEE MS, Shin TG, Lee Y, Kim DH, et al
    Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study.
    Eur Heart J. 2025 Feb 24:ehaf004. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. CHEN G, Gan J, Wu F, Zhou Z, et al
    Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
    Eur Heart J. 2025 Feb 11:ehaf032. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. SQUIRE IB, Sze S
    Prognosis following acute myocardial infarction.
    Eur Heart J. 2025 Feb 10:ehaf056. doi: 10.1093.
    PubMed    
    
    
    
56. ROMAN M, Miksza J, Lai FY, Sze S, et al
    Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study.
    Eur Heart J. 2025;46:535-547.
    PubMed     Abstract available
    
    
    
57. CREA F
    Focus on the extreme of the spectrum: myocardial infarction with no obstructive coronary arteries and ischaemic cardiomyopathy.
    Eur Heart J. 2025;46:399-403.
    PubMed    
    
    
    
58. RASMUSSEN LD, Schmidt SE, Knuuti J, Vrints C, et al
    Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials.
    Eur Heart J. 2025;46:473-483.
    PubMed     Abstract available
    
    
    
59. RASMUSSEN LD, Westra J, Karim SR, Dahl JN, et al
    Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome.
    Eur Heart J. 2025;46:424-435.
    PubMed     Abstract available
    
    
    January 2025
60. BUTLER J, Hammonds K, Talha KM, Alhamdow A, et al
    Incident heart failure and recurrent coronary events following acute myocardial infarction.
    Eur Heart J. 2025 Jan 28:ehae885. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. PEDICINO D, Volpe M
    Weekly Journal Scan: A CLEAR message questions the routine use of spironolactone in acute myocardial infarction.
    Eur Heart J. 2025 Jan 21:ehae936. doi: 10.1093.
    PubMed    
    
    
    
62. REEH J, Afzal S, Wulff AB, Nordestgaard BG, et al
    Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years.
    Eur Heart J. 2025 Jan 17:ehae912. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. LIUZZO G, Patrono C
    Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction.
    Eur Heart J. 2025 Jan 9:ehae897. doi: 10.1093.
    PubMed    
    
    
    
64. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    PubMed     Abstract available
    
    
    
65. BJERKING LH, Skak-Hansen KW, Heitmann M, Hove JD, et al
    Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial.
    Eur Heart J. 2025;46:117-128.
    PubMed     Abstract available
    
    
    
66. WENZL FA, Wang P, Arrigo M, Parenica J, et al
    Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score.
    Eur Heart J. 2025;46:38-54.
    PubMed     Abstract available
    
    
    December 2024
67. ZHANG Y, Yu S, Chen Z, Liu H, et al
    Gestational diabetes and future cardiovascular diseases: associations by sex-specific genetic data.
    Eur Heart J. 2024;45:5156-5167.
    PubMed     Abstract available
    
    
    
68. PEDICINO D, Volpe M
    Weekly Journal Scan: The jury is still out on beta-blockers following acute myocardial infarction with preserved ejection fraction after the ABYSS trial.
    Eur Heart J. 2024 Dec 14:ehae858. doi: 10.1093.
    PubMed    
    
    
    
69. CHAPMAN AR, Taggart C, Boeddinghaus J, Mills NL, et al
    Type 2 myocardial infarction: challenges in diagnosis and treatment.
    Eur Heart J. 2024 Dec 10:ehae803. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
70. BACK M, Hofmann R
    Myocardial infarction and low ambient temperature: does presence or absence of stenoses make a difference?
    Eur Heart J. 2024 Nov 28:ehae820. doi: 10.1093.
    PubMed    
    
    
    
71. AI L, de Freitas Germano J, Huang C, Aniag M, et al
    Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364.
    Eur Heart J. 2024 Nov 27:ehae782. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
    Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
    Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. NARAYANAN S, Vuckovic S, Bergman O, Wirka R, et al
    Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification.
    Eur Heart J. 2024 Nov 18:ehae768. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. BENDRISS E, Pasqueron J, Bardon J
    Coronary air embolism causing myocardial infarction following a blunt chest trauma.
    Eur Heart J. 2024 Nov 14:ehae771. doi: 10.1093.
    PubMed    
    
    
    
75. WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al
    Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
    Eur Heart J. 2024;45:4564-4578.
    PubMed     Abstract available
    
    
    
76. ZURIAGA MA, Yu Z, Matesanz N, Truong B, et al
    Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis.
    Eur Heart J. 2024;45:4601-4615.
    PubMed     Abstract available
    
    
    
77. LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al
    Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
    Eur Heart J. 2024;45:4630-4643.
    PubMed     Abstract available
    
    
    October 2024
78. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
    Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
    Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. HUANG J, He Q, Jiang Y, Wong JMJ, et al
    Low ambient temperature and incident myocardial infarction with or without obstructive coronary arteries: a Chinese nationwide study.
    Eur Heart J. 2024 Oct 28:ehae711. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. KANG D, Choi KH, Kim H, Park H, et al
    Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
    Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al
    Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
    Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
    Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
    Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
    PubMed    
    
    
    
83. LIUZZO G, Patrono C
    Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?
    Eur Heart J. 2024 Oct 18:ehae684. doi: 10.1093.
    PubMed    
    
    
    
84. RAJAKULASINGAM R, Ferreira PF, Scott AD, Khalique Z, et al
    Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance.
    Eur Heart J. 2024 Oct 15:ehae667. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. CREA F
    Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets.
    Eur Heart J. 2024;45:4141-4144.
    PubMed    
    
    
    
86. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
    Plasma proteome and incident myocardial infarction: sex-specific differences.
    Eur Heart J. 2024 Oct 14:ehae658. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. BARTON AK, Lau ES, Gulati M
    Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction.
    Eur Heart J. 2024 Oct 14:ehae657. doi: 10.1093.
    PubMed    
    
    
    
88. DESCH S, Zeymer U, Akin I, Behnes M, et al
    Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial.
    Eur Heart J. 2024;45:4200-4203.
    PubMed    
    
    
    
89. WEINTRAUB WS, Boden WE
    Achieving successful prevention of coronary artery disease: a worldwide call to action.
    Eur Heart J. 2024;45:4197-4199.
    PubMed    
    
    
    
90. LUSEBRINK E, Binzenhofer L, Thiele H
    The DanGer Shock trial: a new dawn but much to uncover.
    Eur Heart J. 2024;45:4181-4183.
    PubMed    
    
    
    
91. LUSCHER TF, Thiele H
    Cardiogenic shock: do we need a paradigm shift?
    Eur Heart J. 2024;45:4178-4180.
    PubMed    
    
    
    
92. 
    Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
    PubMed    
    
    
    
93. AJUFO EC, Tedrow UB
    Refining the stratification of sudden cardiac death risk after myocardial infarction-beyond ejection fraction.
    Eur Heart J. 2024 Oct 8:ehae272. doi: 10.1093.
    PubMed    
    
    
    
94. PEEK N, Hindricks G, Akbarov A, Tijssen JGP, et al
    Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
    Eur Heart J. 2024 Oct 8:ehae326. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. SHIMADA T, Fujisawa N, Otsuka K
    Intracoronary polarimetric signatures of exercise-induced vasospastic angina.
    Eur Heart J. 2024;45:3894.
    PubMed    
    
    
    September 2024
96. XU Y, Li H, Santosa A, Wettermark B, et al
    Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study.
    Eur Heart J. 2024 Sep 30:ehae639. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. CREA F
    New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
    Eur Heart J. 2024;45:3299-3302.
    PubMed    
    
    
    
98. BAIREY MERZ CN
    Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure.
    Eur Heart J. 2024;45:3748-3750.
    PubMed    
    
    
    
99. BODEN WE, De Caterina R, Kaski JC, Bairey Merz N, et al
    Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines.
    Eur Heart J. 2024;45:3701-3706.
    PubMed     Abstract available
    
    
    
100. VRINTS C, Andreotti F, Koskinas KC, Rossello X, et al
     2024 ESC Guidelines for the management of chronic coronary syndromes.
     Eur Heart J. 2024;45:3415-3537.
     PubMed    
     
     
     
101. NURMOHAMED NS, Min JK, Anthopolos R, Reynolds HR, et al
     Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.
     Eur Heart J. 2024;45:3735-3747.
     PubMed     Abstract available
     
     
     
102. VERGALLO R, Liuzzo G
     Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease.
     Eur Heart J. 2024;45:3311-3313.
     PubMed    
     
     
     
103. PEDICINO D, Volpe M
     Weekly Journal Scan: increased incidence of acute myocardial infarction in patients with laboratory-confirmed influenza infection.
     Eur Heart J. 2024 Sep 25:ehae569. doi: 10.1093.
     PubMed    
     
     
     
104. ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al
     Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
     Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
     Great debate: myocardial infarction after cardiac surgery must be redefined.
     Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
     PubMed    
     
     
     
106. BADIMON L, Kiss A, Podesser BK
     Spleen in action for cardioprotection.
     Eur Heart J. 2024;45:3178-3180.
     PubMed    
     
     
     
107. NISHI T, Kume T, Saito Y, Kato K, et al
     Intraplaque haemorrhage, coronary spasm, and resuscitated cardiac arrest in patients with non-obstructive coronary artery disease.
     Eur Heart J. 2024;45:3181-3183.
     PubMed    
     
     
     
108. LIUZZO G, Patrono C
     Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
     Eur Heart J. 2024;45:3108-3110.
     PubMed    
     
     
     
109. LIEDER HR, Paket U, Skyschally A, Rink AD, et al
     Vago-splenic signal transduction of cardioprotection in humans.
     Eur Heart J. 2024;45:3164-3177.
     PubMed     Abstract available
     
     
     
110. GIBSON CM, Duffy D, Bahit MC, Chi G, et al
     Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
     Eur Heart J. 2024 Sep 2:ehae614. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al
     Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
     Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al
     Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
     Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
     Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
     Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. EITEL I, Saraei R, Jurczyk D, Fach A, et al
     Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
     Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. SCHUBERT J, Leosdottir M, Lindahl B, Westerberg J, et al
     Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry.
     Eur Heart J. 2024 Sep 1:ehae576. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. VAN DEN BROEK WWA, Ten Berg JM
     The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
     Eur Heart J. 2024;45:3057-3059.
     PubMed    
     
     
     
117. PRENDERGAST BD, Patterson T, Redwood S
     Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
     Eur Heart J. 2024;45:3042-3044.
     PubMed    
     
     
     August 2024
118. ONDRACEK AS, Afonyushkin T, Aszlan A, Taqi S, et al
     Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.
     Eur Heart J. 2024 Aug 31:ehae584. doi: 10.1093.
     PubMed    
     
     
     
119. GERHARDT T, Landmesser U
     Malondialdehyde-specific natural IgM inhibit NETosis triggered by coronary extracellular vesicles of myocardial infarction patients.
     Eur Heart J. 2024 Aug 31:ehae554. doi: 10.1093.
     PubMed    
     
     
     
120. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
     Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
     Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. 
     Correction to: Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
     Eur Heart J. 2024 Aug 30:ehae581. doi: 10.1093.
     PubMed    
     
     
     
122. MCEVOY JW, Jennings C, Kotseva K, De Bacquer D, et al
     Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study.
     Eur Heart J. 2024 Aug 30:ehae558. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. TARDIF JC, Ouellette K, Boulet J
     Colchicine improves outcomes in coronary disease, but will it in heart failure?
     Eur Heart J. 2024 Aug 30:ehae612. doi: 10.1093.
     PubMed    
     
     
     
124. MAHAFFEY KW, Tuttle KR, Arici M, Baeres FMM, et al
     Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.
     Eur Heart J. 2024 Aug 30:ehae613. doi: 10.1093.
     PubMed     Abstract available
     
     
     
125. CREA F
     Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
     Eur Heart J. 2024;45:2795-2799.
     PubMed    
     
     
     
126. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
     Coronary artery disease management in older adults: revascularization and exercise training.
     Eur Heart J. 2024;45:2811-2823.
     PubMed     Abstract available
     
     
     
127. CREA F
     Heart failure and ischaemic heart disease: new challenges and opportunities.
     Eur Heart J. 2024;45:2681-2685.
     PubMed    
     
     
     
128. BURZOTTA F, Zito A, Aurigemma C, Romagnoli E, et al
     Fractional flow reserve or optical coherence tomography for angiographically intermediate coronary stenoses: 5-year outcomes in the FORZA trial.
     Eur Heart J. 2024;45:2785-2788.
     PubMed    
     
     
     
129. VOLLEBERG R, Damman P, van Royen N
     Dissection-like appearance of focal catheter-induced vasospasm in intracoronary optical coherence tomography.
     Eur Heart J. 2024;45:2793.
     PubMed    
     
     
     
130. CIULLO A, Li L, Li C, Tsi K, et al
     Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated cardioprotection via a novel gene-methylating mechanism.
     Eur Heart J. 2024;45:2660-2673.
     PubMed     Abstract available
     
     
     
131. PEDICINO D, Vergallo R
     Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
     Eur Heart J. 2024;45:2592-2593.
     PubMed    
     
     
     July 2024
132. LIUZZO G, Patrono C
     Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction.
     Eur Heart J. 2024 Jul 26:ehae446. doi: 10.1093.
     PubMed    
     
     
     
133. BESOLA L, Colli A, De Caterina R
     Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
     Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. KANG J, Yun J, Park KW, Park M, et al
     Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
     Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
     PubMed     Abstract available
     
     
     
135. CREA F
     Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
     Eur Heart J. 2024;45:2463-2467.
     PubMed    
     
     
     
136. GIANNITSIS E, Frey N, Katus HA
     Accelerated high sensitivity troponin diagnostics: ready for an even faster pace?
     Eur Heart J. 2024;45:2516-2518.
     PubMed    
     
     
     
137. DIEZ BENAVENTE E, Sakkers TR, van der Harst P, den Ruijter HM, et al
     Atherosclerotic plaque-specific methylation biomarkers in plasma cell-free DNA of female and male patients with coronary artery disease.
     Eur Heart J. 2024;45:2468-2470.
     PubMed    
     
     
     
138. AHMAD Y, Lansky AJ
     Periprocedural myocardial infarction: thresholds of (in)significance.
     Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
     PubMed    
     
     
     
139. JURADO-ROMAN A, Agudo-Quilez P
     Tailoring antithrombotic treatment in patients with acute myocardial infarction and cancer: virtue lies in balance.
     Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093.
     PubMed    
     
     
     
140. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
     Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
     Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
     PubMed     Abstract available
     
     
     
141. FIGTREE GA, Gray MP
     Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet.
     Eur Heart J. 2024;45:2407-2409.
     PubMed    
     
     
     
142. ROGER G, Ducrocq G, Mesnier J, Sayah N, et al
     Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.
     Eur Heart J. 2024;45:2396-2406.
     PubMed     Abstract available
     
     
     
143. BEKKI M, Tahara N, Fukumoto Y
     Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
     Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
     PubMed    
     
     
     June 2024
144. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
     Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
     Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. VILAHUR G, Radike M, Badimon L
     Novel cardioprotective approaches in ischaemic heart disease.
     Eur Heart J. 2024;45:2109-2111.
     PubMed    
     
     
     
146. HOLFELD J, Nagele F, Polzl L, Engler C, et al
     Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
     Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
     PubMed     Abstract available
     
     
     
147. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
     Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
     Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. PEDICINO D, Volpe M
     Weekly Journal Scan: do we need beta-blockers after myocardial infarction with preserved ejection fraction?
     Eur Heart J. 2024 Jun 14:ehae368. doi: 10.1093.
     PubMed    
     
     
     
149. COUGHLAN JJ, Durand R, Byrne RA
     An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
     Eur Heart J. 2024;45:2063-2065.
     PubMed    
     
     
     
150. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
     Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
     Eur Heart J. 2024;45:2052-2062.
     PubMed     Abstract available
     
     
     
151. BEERKENS FJ, Bhatt DL
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
     Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
     PubMed    
     
     
     
152. CULLEN L, Greenslade J, Parsonage W, Stephensen L, et al
     Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.
     Eur Heart J. 2024 Jun 6:ehae343. doi: 10.1093.
     PubMed     Abstract available
     
     
     
153. LIUZZO G, Patrono C
     Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area.
     Eur Heart J. 2024 Jun 1:ehae304. doi: 10.1093.
     PubMed    
     
     
     
154. VERGALLO R, Pedicino D
     Weekly Journal Scan: Impella CP in myocardial infarction complicated by cardiogenic shock.
     Eur Heart J. 2024 Jun 1:ehae306. doi: 10.1093.
     PubMed    
     
     
     
155. UZOKOV J, Alyavi A, Alyavi B, Abdullaev A, et al
     How artificial intelligence can assist with ischaemic heart disease.
     Eur Heart J. 2024;45:1866-1868.
     PubMed    
     
     
     May 2024
156. REN J, Bowyer A, Tian DH, Royse C, et al
     Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
     Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
     PubMed     Abstract available
     
     
     
157. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
     Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
     PubMed     Abstract available
     
     
     
158. KWON O, Ahn JH, Koh JS, Park Y, et al
     Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
     Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
     PubMed     Abstract available
     
     
     
159. CREA F
     The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease.
     Eur Heart J. 2024;45:1769-1773.
     PubMed    
     
     
     
160. NURMOHAMED NS, van Rosendael AR, Danad I, Ngo-Metzger Q, et al
     Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
     Eur Heart J. 2024;45:1783-1800.
     PubMed     Abstract available
     
     
     
161. HARIK L, Gaudino M
     Coronary angiography and bypass surgery: born together and now going separate ways?
     Eur Heart J. 2024;45:1816-1818.
     PubMed    
     
     
     
162. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
     Coronary bypass surgery guided by computed tomography in a low-risk population.
     Eur Heart J. 2024;45:1804-1815.
     PubMed     Abstract available
     
     
     
163. LEE YJ, Shin S, Kwon SW, Suh Y, et al
     Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
     Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
     PubMed     Abstract available
     
     
     
164. DVIR D, Tchetche D, Leon MB, Genereux P, et al
     Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
     Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
     Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
     Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. CREA F
     Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
     Eur Heart J. 2024;45:1577-1581.
     PubMed    
     
     
     
167. TAKAHARA M, Soga Y, Iida O
     Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
     Eur Heart J. 2024;45:1634-1643.
     PubMed     Abstract available
     
     
     
168. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
     Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
     Eur Heart J. 2024;45:1681-1683.
     PubMed    
     
     
     
169. YANG K, Gao R, Chen H, Hu J, et al
     Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
     Eur Heart J. 2024;45:1662-1680.
     PubMed     Abstract available
     
     
     
170. ADLAM D, van Dijk FS, Loeys B
     Genetic testing in patients with unexplained coronary aneurysms or dilation.
     Eur Heart J. 2024;45:1610-1612.
     PubMed    
     
     
     
171. JONES DA, Beirne AM, Kelham M, Wynne L, et al
     Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
     Eur Heart J. 2024;45:1647-1658.
     PubMed     Abstract available
     
     
     
172. XIAO Q, Xu Y, Wang S
     Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
     Eur Heart J. 2024;45:1685.
     PubMed    
     
     
     
173. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
     Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
     Eur Heart J. 2024;45:1540-1549.
     PubMed     Abstract available
     
     
     
174. HEUSCH G, Kleinbongard P
     Cardioprotection research has left its comfort zone.
     Eur Heart J. 2024;45:1568-1570.
     PubMed    
     
     
     
175. VERGALLO R, Patrono C
     Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
     Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
     PubMed    
     
     
     April 2024
176. NGO LTH, Peng Y, Denman R, Yang I, et al
     Long-term outcomes after hospitalization for atrial fibrillation or flutter.
     Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
     PubMed     Abstract available
     
     
     
177. GALIUTO L, Volpe M
     Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
     Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
     PubMed    
     
     
     
178. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
     Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
     Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
     PubMed    
     
     
     
179. VERGALLO R, Galiuto L
     Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
     Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
     PubMed    
     
     
     
180. CREA F
     The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
     Eur Heart J. 2024;45:1183-1187.
     PubMed    
     
     
     
181. KASKI JC, Al-Lamee R, Boden WE
     The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
     Eur Heart J. 2024;45:1201-1204.
     PubMed    
     
     
     
182. AMERI P, Bertero E, Lombardi M, Porto I, et al
     Ischaemic heart disease in patients with cancer.
     Eur Heart J. 2024;45:1209-1223.
     PubMed     Abstract available
     
     
     
183. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
     The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
     Eur Heart J. 2024;45:1193-1195.
     PubMed    
     
     
     
184. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
     Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
     Eur Heart J. 2024;45:1285.
     PubMed    
     
     
     
185. WU VC, Yeh JK, Chen SW, Wu CL, et al
     Syphilis and cardiovascular risk: a Taiwanese registry.
     Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
     PubMed     Abstract available
     
     
     
186. SAYAH N, Bhatt DL, Miller M, Brinton EA, et al
     Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
     Eur Heart J. 2024;45:1173-1176.
     PubMed    
     
     
     March 2024
187. LI L, Pang S, Starnecker F, Mueller-Myhsok B, et al
     Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
     Eur Heart J. 2024 Mar 29:ehae048. doi: 10.1093.
     PubMed     Abstract available
     
     
     
188. WYLD M, Webster AC
     Myocardial infarction and stroke in patients with kidney failure: can we do better?
     Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
     PubMed    
     
     
     
189. TSUDA K, Nagamatsu W, Morii I
     A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
     Eur Heart J. 2024;45:1087.
     PubMed    
     
     
     
190. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
     Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
     Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
     PubMed     Abstract available
     
     
     
191. URSO S, Sadaba R, Dayan V
     Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
     Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
     PubMed    
     
     
     
192. VERGALLO R, Galiuto L
     Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
     Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
     PubMed    
     
     
     
193. GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al
     Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
     Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093.
     PubMed     Abstract available
     
     
     
194. CREA F
     Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
     Eur Heart J. 2024;45:637-641.
     PubMed    
     
     
     
195. JANSEN TPJ, Wentzel JJ, Damman P
     Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
     Eur Heart J. 2024;45:737.
     PubMed    
     
     
     February 2024
196. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
     Human papillomavirus infection and cardiovascular mortality: a cohort study.
     Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
     PubMed     Abstract available
     
     
     
197. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
     Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
     Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2024
198. SENIOR R, Khattar RS
     To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
     Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
     PubMed    
     
     
     
199. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
     Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
200. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
     Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
     Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
     PubMed     Abstract available
     
     
     
201. LI Z, Zhang H, Lin S
     Functionally bicuspid aortic valve leads to myocardial ischaemia.
     Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
     PubMed    
     
     
     December 2023
202. PIRIOU PG, Plessis J, Guerin P
     Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
     Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
     PubMed    
     
     
     November 2023
203. LU ZN, Yang Y, Song G
     A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
     Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
     PubMed    
     
     
     
204. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
     Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
     Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
     PubMed     Abstract available
     
     
     
205. KIM H, Kang DY, Lee J, Choi Y, et al
     Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
     Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.